argenx SE (ARGX)
NASDAQ: ARGX · IEX Real-Time Price · USD
435.49
+1.27 (0.29%)
At close: Jul 2, 2024, 4:00 PM
428.01
-7.48 (-1.72%)
After-hours: Jul 2, 2024, 7:55 PM EDT
argenx SE Revenue
In the year 2023, argenx SE had annual revenue of $39.48M with 270.16% growth.
Revenue (ttm)
$39.48M
Revenue Growth
+270.16%
P/S Ratio
655.55
Revenue / Employee
$34,391
Employees
1,148
Market Cap
25.88B USD
Revenue Chart
* The company reports in EUR currency but revenue data is shown in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 39.48M | 28.82M | 270.16% |
Dec 31, 2022 | 10.67M | -554.42M | -98.11% |
Dec 31, 2021 | 565.09M | 514.79M | 1,023.52% |
Dec 31, 2020 | 50.30M | -37.86M | -42.95% |
Dec 31, 2019 | 88.16M | 63.47M | 257.04% |
Dec 31, 2018 | 24.69M | -19.01M | -43.50% |
Dec 31, 2017 | 43.70M | 28.22M | 182.22% |
Dec 31, 2016 | 15.48M | 8.04M | 108.00% |
Dec 31, 2015 | 7.44M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Cardinal Health | 220.57B |
Koninklijke Philips | 20.19B |
ICON PLC | 8.23B |
Zimmer Biomet Holdings | 7.45B |
STERIS | 5.14B |
ResMed | 4.58B |
Mettler-Toledo International | 3.79B |
West Pharmaceutical Services | 2.93B |
ARGX News
- 7 days ago - argenx Highlights Breadth of Autoimmune Pipeline with New Multifocal Motor Neuropathy Data at 2024 Peripheral Nerve Society Annual Meeting - GlobeNewsWire
- 8 days ago - Why Is European Drugmaker Argenx Stock Trading Higher On Monday? - Benzinga
- 11 days ago - argenx Announces FDA Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy - GlobeNewsWire
- 16 days ago - argenx to unveil its ‘Vision 2030: Taking Breakthrough Science to 50,000 Patients' during its Upcoming R&D Day on July 16, 2024 - GlobeNewsWire
- 4 weeks ago - argenx to Present at Goldman Sachs 45th Annual Global Healthcare Conference - GlobeNewsWire
- 7 weeks ago - argenx Reports First Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - argenx announces results of Annual General Meeting of Shareholders - GlobeNewsWire
- 2 months ago - argenx to Present at BofA Securities 2024 Health Care Conference - GlobeNewsWire